Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
156.12+1.66 (1.07%)See all stock information showing slide 1 of 1. Johnson & Johnson First Quarter 2025 Quarterly Earnings Call Tuesday, April 15, 2025 Event & presentationWebcast jnj.com Investor relations The J&J value At Johnson & Johnson, we believe health is everything. Our strength in ...
Stock Advisor Epic Epic Plus Fool Portfolios Fool One Motley Fool Money Around the Globe Fool UK Fool Australia Fool Canada Free Tools CAPS Stock Ratings Discussion Boards Calculators Financial Dictionary Affiliates & Friends Motley Fool Asset Management ...
you agree to the terms of use & privacy policy bull or bear, seeking alpha is there markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. create free account jn...
Free Cash Flow / Share (TTM) $7.50 Full Cash Flow Statement » JNJ:CA Long Term Solvency Total Debt / Equity (MRQ) 52.92% Total Debt / Capital (MRQ) 34.61% LT Debt / Equity (MRQ) 44.55% LT Debt / Total Capital (MRQ) 29.13% Total Liabilities / Total Assets (MRQ) 60.31% Discover...
Spreads Protection Strategies Straddles & Strangles Horizontal Spreads Butterfly Spreads Condor Strategies company News & Headlines Key Statistics SEC Filings Competitors Stock Comparison Insider Trades analysts Earnings Estimates Analyst Ratings financials Financial Summary Income Statement Balance Sheet Cash Flow...
Thank you, Jessica, and hello, everyone. Thank you for joining today's call. Overall, Johnson & Johnson delivered solid top and bottom line, as well as free cash flow growth in the quarter. Our Innovative Medicines business made great progress in the second quarter. ...
Both Corus and J&J are not cheap in terms of valuation, but they are not too expensive either. Corus is making 8 times free cash flow and J&J has a P/E ratio of 17.6 times. The reason I decided to buy these stocks is because I believe they would be great additions to mydividend gr...
*Stock Advisor returns as of January 21, 2025 Additionally, several of the products and compounds discussed today are being developed in collaboration with strategic partners or licensed from other companies. This slide acknowledges those relationships. Moving to today's agenda. Joaquin Duato, our cha...